Cardiol Therapeutics Statistics

Total Valuation

CRDL has a market cap or net worth of $91.85 million. The enterprise value is $75.04 million.

Market Cap	91.85M
Enterprise Value	75.04M

Important Dates

The next estimated earnings date is Tuesday, August 26, 2025, after market close.

Earnings Date	Aug 26, 2025
Ex-Dividend Date	n/a

Share Statistics

CRDL has 82.65 million shares outstanding. The number of shares has increased by 15.56% in one year.

Current Share Class	82.65M
Shares Outstanding	82.65M
Shares Change (YoY)	+15.56%
Shares Change (QoQ)	+2.74%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	79.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.51
P/TBV Ratio	7.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.26, with a Debt / Equity ratio of 0.01.

Current Ratio	3.26
Quick Ratio	3.05
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -190.11% and return on invested capital (ROIC) is -132.69%.

Return on Equity (ROE)	-190.11%
Return on Assets (ROA)	-89.03%
Return on Invested Capital (ROIC)	-132.69%
Return on Capital Employed (ROCE)	-227.63%
Revenue Per Employee	n/a
Profits Per Employee	-$1.38M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.50% in the last 52 weeks. The beta is 0.79, so CRDL's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-44.50%
50-Day Moving Average	1.34
200-Day Moving Average	1.31
Relative Strength Index (RSI)	41.44
Average Volume (20 Days)	979,918

Short Selling Information

The latest short interest is 1.76 million, so 2.13% of the outstanding shares have been sold short.

Short Interest	1.76M
Short Previous Month	1.72M
Short % of Shares Out	2.13%
Short % of Float	2.21%
Short Ratio (days to cover)	4.88

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-28.04M
Pretax Income	-21.99M
Net Income	-24.90M
EBITDA	-27.96M
EBIT	-28.04M
Earnings Per Share (EPS)	-$0.33

Full Income Statement

Balance Sheet

The company has $16.21 million in cash and $104,818 in debt, giving a net cash position of $16.10 million or $0.19 per share.

Cash & Cash Equivalents	16.21M
Total Debt	104,818
Net Cash	16.10M
Net Cash Per Share	$0.19
Equity (Book Value)	12.24M
Book Value Per Share	0.15
Working Capital	12.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.60 million and capital expenditures -$20,711, giving a free cash flow of -$18.41 million.

Operating Cash Flow	-17.60M
Capital Expenditures	-20,711
Free Cash Flow	-18.41M
FCF Per Share	-$0.22

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRDL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.56%
Shareholder Yield	-15.56%
Earnings Yield	-27.11%
FCF Yield	-20.04%

Analyst Forecast

The average price target for CRDL is $9.00, which is 710.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	710.81%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2